Integral Diagnostics Ltd. ( (AU:IDX) ) has issued an update.
Challenger Limited has become a substantial holder in Integral Diagnostics Limited, acquiring a significant voting power of 5.40%. This acquisition reflects Challenger Limited’s strategic interest in Integral Diagnostics, potentially impacting the company’s market dynamics and shareholder interests.
More about Integral Diagnostics Ltd.
YTD Price Performance: -18.90%
Average Trading Volume: 1,437,565
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$877.5M
Learn more about IDX stock on TipRanks’ Stock Analysis page.